p-Index From 2021 - 2026
0.444
P-Index
This Author published in this journals
All Journal VISIKES
Wibowo S, F.X. Sulistiyanto
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : visikes

Analysis Of The Use Of Oral Antidiabetic Drugs In Type II Diabetes Mellitus Patients At X Hospital Semarang City Wibowo S, F.X. Sulistiyanto; A., Dhimas; C.S., Insania
VISIKES Vol. 24 No. 2 (2025): VISIKES
Publisher : Dian Nuswantoro Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60074/visikes.v24i2.13849

Abstract

Diabetes mellitus is a long-term condition marked by high blood sugar levels. It stems from metabolic endocrine disorders that may result from reduced insulin secretion, reduced insulin sensitivity, or both. Management of type II DM often includes antidiabetic treatment, which may consist of one medication or a combination. This research aims to describe patient characteristics, outline medication usage, report rates of Glucose Ad Random (GAR) reduction, and assess the efficacy of single versus combination antidiabetic drugs in type 2 DM patients admitted to X Hospital in Semarang City. The study uses an analytical observational approach with retrospective data collection and purposive sampling. Findings showed that 52.13% were women and 42.02% were aged 56-65 years (late elderly group). Also, 70.21% had Type II DM with complications, and 57.45% had hospital stays of 1-4 days. The most used single antidiabetic accounted for 53.19% of cases. Paired Sample T-Test results for both single and combination antidiabetics showed p <0.05, indicating both therapies effectively reduce GAR. Single antidiabetic therapy yielded a 22.46% reduction, while the combination led to a 45.36% decrease. The T-Test results further showed the combination was more effective, with an average GAR reduction of 111.2386 mg/dL. Hospitals are expected to continue using combination oral antidiabetics as per the hospital formulary to maintain blood sugar control. Diabetes Mellitus patients should monitor blood sugar routinely, take medications regularly, and follow a recommended diet, healthy lifestyle, and regular exercise. This helps prevent complications. Future researchers are encouraged to examine the relationship between laboratory data and other factors such as BMI, diet, and stress.
Cost-Effectiveness of Antihypertensive Therapy in Ischemic Stroke Patients Nurul Janah, Rowiyah Sufi; Wibowo S, F.X. Sulistiyanto; Advistasari, Yustisia Dian
VISIKES Vol. 25 No. 1 (2026): VISIKES
Publisher : Dian Nuswantoro Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.60074/visikes.v25i1.16101

Abstract

Ischemic stroke is an acute condition caused by the interruption of blood flow to the brain due to blood vessel obstruction, which can lead to permanent disability and death. Hypertension is a major risk factor and the most common comorbidity in ischemic stroke patients. The use of antihypertensive therapy in stroke patients plays a crucial role in controlling blood pressure and preventing complications, but it also increases the burden of medical costs. Therefore, a pharmacoeconomic evaluation is necessary to assess the cost-effectiveness of the therapy. This study aims to analyze patient characteristics and evaluate the cost-effectiveness of oral antihypertensive therapy in ischemic stroke patients at Hospital "X" from September 2024 to August 2025. The method used was Cost-Effectiveness Analysis (CEA) with the Average Cost-Effectiveness Ratio (ACER), in which the therapy with the lowest ACER is considered the most cost-effective. The results showed that the majority of patients were male (32 patients), and the largest age group was elderly aged 56–65 years (23 patients), with an average length of stay of 4.63 days. As a single therapy, calcium channel blockers (CCBs) demonstrated the lowest ACER value of Rp34,013.77, making them the most cost-effective therapy. In combination therapy, the combination of CCBs and beta-blockers had the lowest ACER value (Rp29,766.44). These results indicate that selecting the right antihypertensive therapy can improve cost efficiency and support more rational healthcare delivery.